These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3161813)

  • 1. Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women.
    Lobo RA; Roy S; Shoupe D; Endres DB; Adams JS; Rude RK; Singer FR
    Horm Metab Res; 1985 Jul; 17(7):370-3. PubMed ID: 3161813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium metabolism in post-menopausal women.
    Mendoza C; Ortega E; Ruiz E; Carreras A; Osorio C
    Rev Esp Fisiol; 1985 Dec; 41(4):447-50. PubMed ID: 3938042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
    Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
    J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
    Selby PL; Peacock M
    N Engl J Med; 1986 Jun; 314(23):1481-5. PubMed ID: 3754618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Lane G; Townsend PT; Young O; Whitehead MI
    Eur J Clin Invest; 1983 Dec; 13(6):481-7. PubMed ID: 6315447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in man.
    Thomsen K; Riis BJ; Hummer L; Christiansen C
    Acta Vitaminol Enzymol; 1985; 7(3-4):167-71. PubMed ID: 3879105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D; Montz FJ; Lobo RA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Osteoporos Int; 1999; 9(4):351-7. PubMed ID: 10550453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic parameters and steroid levels in postmenopausal women receiving lower doses of natural estrogen replacement.
    Lobo RA; Brenner P; Mishell DR
    Obstet Gynecol; 1983 Jul; 62(1):94-8. PubMed ID: 6856230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC; Shieh SD; Chyr SH; Lin SH; Li BL; Diang LK; Chen WQ; Lin YF
    Diabetes Res; 1993; 22(3):97-104. PubMed ID: 8076446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
    Stock JL; Coderre JA; Mallette LE
    J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical parameters associated with low bone density in healthy men and women.
    Sherman SS; Tobin JD; Hollis BW; Gundberg CM; Roy TA; Plato CC
    J Bone Miner Res; 1992 Oct; 7(10):1123-30. PubMed ID: 1456082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.